Punt CJ - Search Results

1

Advanced colorectal cancer, refractory to infusional fluorouracil treatment: efficacy of second line fluorouracil in combination with a different biochemical modulation.

van Halteren HK, Wagener DJ, Vreugdenhil G, Punt CJ. van Halteren HK, et al. Among authors: punt cj. Anticancer Res. 1997 Jul-Aug;17(4A):2715-9. Anticancer Res. 1997. PMID: 9252703

2

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study.

Punt CJ, de Mulder PH, Burghouts JT, Wagener DJ. Punt CJ, et al. Cancer Chemother Pharmacol. 1992;29(4):326-8. doi: 10.1007/BF00685954. Cancer Chemother Pharmacol. 1992. PMID: 1537082 Clinical Trial.

3

Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.

Punt CJ, de Mulder PH, Burghouts JT, Wagener DJ. Punt CJ, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):208-10. Semin Oncol. 1992. PMID: 1557649 Clinical Trial.

4

Current status and future directions in the perioperative treatment of pancreatic cancer.

Wagener DJ, Punt CJ, Wilke H. Wagener DJ, et al. Among authors: punt cj. Ann Oncol. 1994;5 Suppl 3:87-90. doi: 10.1093/annonc/5.suppl_3.s87. Ann Oncol. 1994. PMID: 8204535 Review.

5

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.

Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y. Punt CJ, et al. Cancer. 1993 Oct 1;72(7):2107-11. doi: 10.1002/1097-0142(19931001)72:7<2107::aid-cncr2820720708>3.0.co;2-m. Cancer. 1993. PMID: 8374869 Clinical Trial.

6

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

Punt CJ, Humblet Y, Roca E, Dirix LY, Wainstein R, Polli A, Corradino I. Punt CJ, et al. Br J Cancer. 1996 Mar;73(6):803-4. doi: 10.1038/bjc.1996.140. Br J Cancer. 1996. PMID: 8611384 Free PMC article. Clinical Trial.

7

Weekly chronomodulated 48 h infusion of high-dose 5-fluorouracil modulated by methotrexate and (6S)-leucovorin in advanced colorectal cancer: a phase IB study.

Punt CJ, Kamm YL, Wagener DJ. Punt CJ, et al. Anticancer Drugs. 1997 Jun;8(5):454-8. doi: 10.1097/00001813-199706000-00006. Anticancer Drugs. 1997. PMID: 9215607

8

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

Punt CJ, van Herpen CM, Jansen RL, Vreugdenhil G, Muller EW, de Mulder PH. Punt CJ, et al. Br J Cancer. 1997;76(2):266-9. doi: 10.1038/bjc.1997.374. Br J Cancer. 1997. PMID: 9231931 Free PMC article. Clinical Trial.

9

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

10

A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study.

van Tellingen O, Punt CJ, Awada A, Wagener DJ, Piccart MJ, Groot Y, Schaaf LJ, Henrar RE, Nooijen WJ, Beijnen JH. van Tellingen O, et al. Among authors: punt cj. Cancer Chemother Pharmacol. 1998;41(5):377-84. doi: 10.1007/s002800050754. Cancer Chemother Pharmacol. 1998. PMID: 9523733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters